July 20, 2015 | The Israeli drug development company Chiasma announced that it raised $102 million in a NASDAQ IPO. The company sold 6.3 million shares at $16 a piece with a market cap of $562 million. Chiasma had raised $70 million previously in a private placement. Chiasma also recently submitted its request to begin marketing its treatment for acromegaly. Chiasma was founded in 2001 and is headquartered in Jerusalem.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

UN Honors Israeli Food Exec For Sustainability Work
September 26, 2023

Startup Unveils Tech To Speed Up Growth Of Cultivated Meat
September 26, 2023

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Facebook comments